Biocept, Inc. short interest in 2021
In 2021, Biocept, Inc.'s disclosed short interest ran from 3.13% of shares outstanding on 15 Jan 2021 to 2.38% on 31 Dec 2021, a change of -0.75 percentage points. The year's high was 6.67% on 15 Sep 2021 and its low 2.21% on 15 Dec 2021, averaging 4.39% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.39 days on 28 May 2021. Full history: Biocept, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2021 in figures
- Start of year
- 3.13% (15 Jan 2021)
- End of year
- 2.38% (31 Dec 2021)
- Change
- -0.75 pp
- High
- 6.67% (15 Sep 2021)
- Low
- 2.21% (15 Dec 2021)
- Average
- 4.39%
- Highest days to cover
- 5.39 (28 May 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 3.13% | 1.01 | |
| 29 Jan 2021 | 3.36% | 1.00 | |
| 12 Feb 2021 | 2.81% | 1.00 | |
| 26 Feb 2021 | 2.90% | 1.02 | |
| 15 Mar 2021 | 4.29% | 1.70 | |
| 31 Mar 2021 | 6.61% | 1.09 | results (8-K), 10-K filed |
| 15 Apr 2021 | 5.78% | 2.22 | |
| 30 Apr 2021 | 5.39% | 2.93 | |
| 14 May 2021 | 5.82% | 3.79 | 10-Q filed, results (8-K) |
| 28 May 2021 | 4.43% | 5.39 | |
| 15 Jun 2021 | 4.89% | 3.15 | |
| 30 Jun 2021 | 5.05% | 1.00 | |
| 15 Jul 2021 | 6.23% | 2.89 | |
| 30 Jul 2021 | 5.83% | 1.64 | |
| 13 Aug 2021 | 5.08% | 3.57 | |
| 31 Aug 2021 | 6.59% | 1.00 | 10-Q filed, results (8-K) |
| 15 Sep 2021 | 6.67% | 2.63 | |
| 30 Sep 2021 | 3.31% | 1.53 | |
| 15 Oct 2021 | 3.82% | 1.41 | |
| 29 Oct 2021 | 3.14% | 3.18 | |
| 15 Nov 2021 | 2.42% | 2.22 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 3.12% | 1.88 | |
| 15 Dec 2021 | 2.21% | 1.00 | |
| 31 Dec 2021 | 2.38% | 2.37 |
See also: Biocept, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.